Dr. Abeer Al Rabayah, is the head of the Center for Drug Policy and Technology Assessment (CDPTA) at King Hussein Cancer Center (KHCC). The CDPTA provides health technology assessment, Pharmacoeconomics, Pharmacovigilance and drug information services to decision makers and members of the pharmacy and therapeutic committee.

Dr. Al Rabayah has a diversified experience; she has had the opportunity to provide her expertise to multinational pharmaceutical companies, national pharmaceutical manufacturers, academia, and international pharmaceutical projects.

She holds a BSc in Pharmacy from Jordan University, a master of art in business administration from Jordan University and a master of science in international health technology assessment, pricing, and reimbursement from the University of Sheffield-United Kingdome. During the last 6 years, Dr. Al Rabayah has lead the development and appraisal of many cost effectiveness decision analytical models, prepared health technology assessment reports to inform decisions regarding new formulary additions, lead and implemented a pharmacovigilance and a drug use evaluation programs at KHCC.

Dr. Al Rabayah has had a strategic role in capacity building of Jordanian and non-Jordanian pharmacists in conducting Pharmacoeconomics studies. She participated as a key faculty member in delivering short Pharmacoeconomics courses in collaboration with the World Health Organization in low-middle income countries. Recently, Dr. Al Rabayah has been selected as a member of the national Jordanian pricing committee at the Jordan Food and Drug Administration.